The Liquid Biopsy and Tumor Progression in Breast Cancer
31 – 40 of 139
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy
- Contribution to journal › Article
-
Mark
Protocol for the T-REX-trial : Tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - An open, multicentre, randomised non-inferiority phase 3 trial
- Contribution to journal › Article
-
Mark
Breast Cancer Diagnosis Using Extended-Wavelength–Diffuse Reflectance Spectroscopy (EW-DRS) : Proof of Concept in Ex Vivo Breast Specimens Using Machine Learning
- Contribution to journal › Article
-
Mark
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer : data from the randomized SBII:2 trial
- Contribution to journal › Article
-
Mark
Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning : External Validation and Further Model Development
- Contribution to journal › Article
-
Mark
Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model
- Contribution to journal › Article
-
Mark
A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy
- Contribution to journal › Article
-
Mark
The implementation of NILS : A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
- Contribution to journal › Article
-
Mark
Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study
- Contribution to journal › Article
-
Mark
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI) : a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study
- Contribution to journal › Article
